David R. Rahn & Associates Inc. Bristol Myers Squibb CO Transaction History

David R. Rahn & Associates Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 14, 2020	SELL	$54.82 - $64.09 $591,836 - $691,915	-10,796 Closed	0 $0
Q1 2020 Apr 20, 2020	SELL	$46.4 - $67.43 $48,673 - $70,734	-1,049 Reduced 8.86%	10,796 $602,000
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $582,892 - $760,330	11,845 New	11,845 $760,000
Q4 2017 Jan 26, 2018	SELL	$59.94 - $65.35 $2.03 Million - $2.22 Million	-33,907 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$55.23 - $63.74 $1.87 Million - $2.16 Million	33,907	33,907 $2.16 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of David R. Rahn & Associates Inc., based on Form 13F filings with the SEC.

Stay updated on David R. Rahn & Associates Inc. with notifications on news.